Aarti Drugs Ltd Stock News

Aarti Drugs Ltd Share Price
Detail Overview
Pharmaceuticals - Indian - Bulk DrugsNSE
₹484.50
-14.40(-2.89%)
As on 20 Nov 2026 at 15:58
As of 20 Nov 2026 at 15:58, Aarti Drugs Ltd is trading at ₹484.50. The 52-week range stands at ₹318.95–₹527.50, with a market cap of ₹4.42 thousand crore. At a P/E of 23.41 and a dividend yield of 0.41%, it is a small-cap stock in the Pharmaceuticals sector.

AARTIDRUGS Price Chart

Market Cap
₹4.42K Cr
PE Ratio
23.41
ROCE
12.90%

Aarti Drugs Ltd Latest News

View More
15 NOV 2026 | Sunday
Aarti Drugs' Chairman Emeritus, Shri Chandrakant Gogri, passed away on November 15, 2026
27 OCT 2026 | Tuesday
Aarti Drugs to convene a board meeting November 3 to review financial results
07 OCT 2026 | Wednesday
Aarti Drugs reported securities dematerialization processing confirmation from MUFG Intime India
29 SEPT 2026 | Tuesday
Aarti Drugs will halt trading ahead of financial results declaration in late September
26 SEPT 2026 | Saturday
Aarti Drugs appoints Adhish Patil as Managing Director, effective October 1, 2026
25 AUG 2026 | Tuesday
Aarti Drugs to convene board meeting August 27th to approve a stock option plan
24 AUG 2026 | Monday
Aarti Drugs to convene board meeting August 27th to approve a stock option plan
01 AUG 2026 | Saturday
Aarti Drugs’ revenue increased 19% to Rs 703.6 crore for the quarter ended June 30, 2026
31 JUL 2026 | Friday
Aarti Drugs names Rashesh Gogri Chairman, Adhish Patil Managing Director, effective October 1
31 JUL 2026 | Friday
Aarti Drugs names Rashesh Gogri Chairman, appoints Adish Patil as Managing Director

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now